Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.23

-0.04 (-0.55%)

At close: Jul 3, 2025, 1:00 PM

7.25

+0.02 (0.28%)

After-hours: Jul 3, 2025, 3:52 PM EDT

Entrada Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	172.22	210.78	129.01	-	-	-	Upgrade
Revenue Growth (YoY)	5.74%	63.38%	-	-	-	-	Upgrade
Cost of Revenue	128.77	125.31	99.88	66.61	35.93	-	Upgrade
Gross Profit	43.45	85.48	29.13	-66.61	-35.93	-	Upgrade
Selling, General & Admin	39.34	38.47	32.29	30.64	15.2	5.57	Upgrade
Research & Development	-	-	-	-	-	21.1	Upgrade
Operating Expenses	39.34	38.47	32.29	30.64	15.2	26.67	Upgrade
Operating Income	4.11	47.01	-3.16	-97.25	-51.13	-26.67	Upgrade
Interest & Investment Income	19.7	19.47	15.22	2.63	0.04	0.16	Upgrade
EBT Excluding Unusual Items	23.81	66.49	12.06	-94.62	-51.08	-26.5	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-0.07	-0.02	Upgrade
Pretax Income	23.81	66.49	12.06	-94.62	-51.16	-26.52	Upgrade
Income Tax Expense	-0.97	0.86	18.74	-	-	-	Upgrade
Net Income	24.78	65.63	-6.69	-94.62	-51.16	-26.52	Upgrade
Net Income to Common	24.78	65.63	-6.69	-94.62	-51.16	-26.52	Upgrade
Shares Outstanding (Basic)	39	37	33	31	6	1	Upgrade
Shares Outstanding (Diluted)	41	39	33	31	6	1	Upgrade
Shares Change (YoY)	20.56%	18.01%	5.62%	399.27%	467.09%	18.45%	Upgrade
EPS (Basic)	0.63	1.76	-0.20	-3.02	-8.16	-24.00	Upgrade
EPS (Diluted)	0.61	1.68	-0.20	-3.02	-8.16	-24.00	Upgrade
Free Cash Flow	-58.01	-44.72	134.19	-96.67	-55.44	-27.89	Upgrade
Free Cash Flow Per Share	-1.43	-1.15	4.06	-3.09	-8.85	-25.23	Upgrade
Gross Margin	25.23%	40.55%	22.58%	-	-	-	Upgrade
Operating Margin	2.38%	22.30%	-2.45%	-	-	-	Upgrade
Profit Margin	14.39%	31.14%	-5.18%	-	-	-	Upgrade
Free Cash Flow Margin	-33.68%	-21.21%	104.01%	-	-	-	Upgrade
EBITDA	7.89	50.78	-0.32	-95.35	-50.01	-26.34	Upgrade
EBITDA Margin	4.58%	24.09%	-0.25%	-	-	-	Upgrade
D&A For EBITDA	3.79	3.77	2.84	1.9	1.12	0.33	Upgrade
EBIT	4.11	47.01	-3.16	-97.25	-51.13	-26.67	Upgrade
EBIT Margin	2.38%	22.30%	-2.45%	-	-	-	Upgrade
Effective Tax Rate	-	1.29%	155.45%	-	-	-	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q